Momenta Pharmaceuticals, Inc. (MNTA)

[biopearl]

Still, its a little disconcerting to see the DOJ appear to agree with one pillar of the DC argument (the interpretation of Fig. 1) even though the court of appeals found the findings in Fig1 supportive of the indefiniteness argument. Fortunately, the other pillar of the case, the disconjugate fillings by TEVA re use of molecular weight definitions appears strong and perhaps will carry the day. This seems to be acknowledged by the DOJ (as well as the CAFC) and should be a strong positive for MNTA. as noted by Dew. bp